Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHARDA CROPCHEM 2021-22 Annual Report Analysis
Fri, 8 Jul

SHARDA CROPCHEM has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

SHARDA CROPCHEM Income Statement Analysis

  • Operating income during the year rose 49.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 61.7% YoY during the fiscal. Operating profit margins witnessed a fall and down at 19.4% in FY22 as against 18.0% in FY21.
  • Depreciation charges increased by 43.9% and finance costs decreased by 7.5% YoY, respectively.
  • Other income declined by 56.1% YoY.
  • Net profit for the year grew by 52.4% YoY.
  • Net profit margins during the year grew from 9.6% in FY21 to 9.8% in FY22.

SHARDA CROPCHEM Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 23,956 35,798 49.4%
Other income Rs m 658 289 -56.1%
Total Revenues Rs m 24,614 36,086 46.6%
Gross profit Rs m 4,303 6,957 61.7%
Depreciation Rs m 1,704 2,453 43.9%
Interest Rs m 162 150 -7.5%
Profit before tax Rs m 3,095 4,642 50.0%
Tax Rs m 802 1,150 43.3%
Profit after tax Rs m 2,292 3,493 52.4%
Gross profit margin % 18.0 19.4
Effective tax rate % 25.9 24.8
Net profit margin % 9.6 9.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

SHARDA CROPCHEM Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 17 billion as compared to Rs 11 billion in FY21, thereby witnessing an increase of 48.5%.
  • Current assets rose 36% and stood at Rs 29 billion, while fixed assets rose 17% and stood at Rs 14 billion in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 42 billion as against Rs 33 billion during FY21, thereby witnessing a growth of 29%.

SHARDA CROPCHEM Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 16,143 19,125 18.5
 
Current Liabilities Rs m 11,399 16,929 48.5
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 32,611 42,157 29.3
 
Current assets Rs m 20,999 28,526 35.8
Fixed Assets Rs m 11,612 13,631 17.4
Total Assets Rs m 32,611 42,157 29.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



SHARDA CROPCHEM Cash Flow Statement Analysis

  • SHARDA CROPCHEM's cash flow from operating activities (CFO) during FY22 stood at Rs 3 billion, an improvement of 8.4% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -2 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs -910 million on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs -289 million from the Rs 78 million net cash flows seen during FY21.

SHARDA CROPCHEM Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 2,464 2,671 8.4%
Cash Flow from Investing Activities Rs m -2,816 -2,079 -
Cash Flow from Financing Activities Rs m 434 -910 -
Net Cash Flow Rs m 78 -289 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for SHARDA CROPCHEM

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 38.7, an improvement from the EPS of Rs 25.4 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 645.1, stands at 16.7 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.0 times, while the price to sales ratio stands at 1.6 times.
  • The company's price to cash flow (P/CF) ratio stood at 7.2 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 265.5 396.8
TTM Earnings per share Rs 25.4 38.7
Diluted earnings per share Rs 25.4 38.7
Price to Cash Flow x 6.5 7.2
TTM P/E ratio x 11.3 16.7
Price / Book Value ratio x 1.3 2.2
Market Cap Rs m 21,563 42,719
Dividends per share (Unadj.) Rs 5.0 6.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for SHARDA CROPCHEM

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.7x during FY22, from 1.8x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 31.9x during FY22, from 20.1x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 18.3% during FY22, from 14.2% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 25.1% during FY22, from 20.2% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 8.6% during FY22, from 7.5% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.8 1.7
Debtors’ Days Days 1,771 1,570
Interest coverage x 20.1 31.9
Debt to equity ratio x 0.0 0.0
Return on assets % 7.5 8.6
Return on equity % 14.2 18.3
Return on capital employed % 20.2 25.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how SHARDA CROPCHEM has performed over the last 5 years, please visit here.

SHARDA CROPCHEM Share Price Performance

Over the last one year, SHARDA CROPCHEM share price has moved up from Rs 354.4 to Rs 645.1, registering a gain of Rs 290.7 or around 82.0%.

Overall, the S&P BSE SENSEX is up 3.1% over the year.

(To know more, check out historical annual results for SHARDA CROPCHEM and quarterly results for SHARDA CROPCHEM)

Annual Report FAQs

What is the current share price of SHARDA CROPCHEM?

SHARDA CROPCHEM currently trades at Rs 379.2 per share. You can check out the latest share price performance of SHARDA CROPCHEM here...

What was the revenue of SHARDA CROPCHEM in FY22? How does it compare to earlier years?

The revenues of SHARDA CROPCHEM stood at Rs 36,086 m in FY22, which was up 46.6% compared to Rs 24,614 m reported in FY21.

SHARDA CROPCHEM's revenue has grown from Rs 17,232 m in FY18 to Rs 36,086 m in FY22.

Over the past 5 years, the revenue of SHARDA CROPCHEM has grown at a CAGR of 20.3%.

What was the net profit of SHARDA CROPCHEM in FY22? How does it compare to earlier years?

The net profit of SHARDA CROPCHEM stood at Rs 3,493 m in FY22, which was up 52.4% compared to Rs 2,292 m reported in FY21.

This compares to a net profit of Rs 1,647 m in FY20 and a net profit of Rs 1,763 m in FY19.

Over the past 5 years, SHARDA CROPCHEM net profit has grown at a CAGR of 16.3%.

What does the cash flow statement of SHARDA CROPCHEM reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of SHARDA CROPCHEM reveals:

  • Cash flow from operations increased in FY22 and stood at Rs 2,671 m as compared to Rs 2,464 m in FY21.
  • Cash flow from investments increased in FY22 and stood at Rs -2,079 m as compared to Rs -2,816 m in FY21.
  • Cash flow from financial activity decreased in FY22 and stood at Rs -910 m as compared to Rs 434 m in FY21.

Here's the cash flow statement of SHARDA CROPCHEM for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations1705,5611,4632,4642,671
From Investments-1,628-3,598-678-2,816-2,079
From Financial Activity1,322-2,154-597434-910
Net Cashflow-110-10627178-289

What does the Key Ratio analysis of SHARDA CROPCHEM reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of SHARDA CROPCHEM reveals:

  • Operating profit margins witnessed a fall and down at 19.4% in FY22 as against 18.0% in FY21.
  • Net profit margins grew from 9.6% in FY21 to 9.8% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.0 as compared to 0.0 in FY21.

Here's the ratio/financial analysis of SHARDA CROPCHEM for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)20.916.714.718.019.4
Net Profit Margin (%)11.28.88.29.69.8
Debt to Equity Ratio (x)0.00.00.00.00.0

Read: Latest Annual Report Analysis of SHARDA CROPCHEM

Equitymaster requests your view! Post a comment on "SHARDA CROPCHEM 2021-22 Annual Report Analysis". Click here!